Saarbrücken, Germany

Duy-Khiet Ho


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Duy-Khiet Ho: Innovator in Aminoglycoside Derivatives

Introduction

Duy-Khiet Ho is a notable inventor based in Saarbrücken, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel therapeutic agents.

Latest Patents

Duy-Khiet Ho holds a patent for "Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function." This invention relates to conjugates of aminoglycosides and terpenoids, specifically sesquiterpenoids. The patent also covers nano-assemblies formed by these conjugates and outlines a method for producing them. The inventive conjugates and nano-assemblies are intended for therapeutic use, particularly in treating infectious diseases. Notably, the preferred embodiments involve farnesylated aminoglycosides, where farnesol and its derivatives serve as carriers for the aminoglycosides while also exhibiting pharmaceutical activity, especially quorum sensing inhibitory activity.

Career Highlights

Duy-Khiet Ho is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he conducts his research and development activities. His work focuses on innovative solutions to combat infectious diseases through advanced chemical compounds.

Collaborations

Some of his notable coworkers include Brigitta Loretz and Claus-Michael Lehr, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Duy-Khiet Ho's work in the field of aminoglycoside derivatives showcases his commitment to advancing therapeutic options for infectious diseases. His innovative approach and collaboration with esteemed colleagues highlight the importance of teamwork in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…